- $6.45bn
- $4.98bn
- $1.61bn
Annual balance sheet for UiPath, fiscal year end - January 31st, USD millions except per share, conversion factor applied.
2022 January 31st | 2023 January 31st | 2024 January 31st | 2025 January 31st | 2026 January 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | PRESS |
| Standards: | USG | USG | USG | USG | — |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 1,865 | 1,757 | 1,880 | 1,630 | 1,472 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 337 | 443 | 520 | 540 | 581 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 2,277 | 2,344 | 2,580 | 2,339 | 2,244 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 66.1 | 81.1 | 80.1 | 99.2 | 110 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 2,572 | 2,735 | 2,955 | 2,865 | 3,179 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 528 | 626 | 712 | 799 | 905 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 651 | 815 | 939 | 1,020 | 1,097 |
| Redeemable Preferred Stock | |||||
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 1,922 | 1,920 | 2,016 | 1,846 | 2,083 |
| Total Liabilities & Shareholders' Equity | 2,572 | 2,735 | 2,955 | 2,865 | 3,179 |
| Total Common Shares Outstanding |